Manufacturing licence restriction at Recipharm,Ashton-u-Lyne, UK
Five non-critical highly potent products supplied from the Recipharm facility located in Ashton-u-Lyne, UK
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
ISPE releases data integrity guidance
Guide integrates cultural excellence, critical thinking skills into data integrity practices
After 2 years, double-digit growth beckons big pharma cos: CRISIL Ratings
Revenues seen up 10-12 per cent this fiscal; operating margins seen stable at 18-20 per cent
DCGI approves clinical trials for plastic surgery, dermatology and Cosmetic Products in India
The specialized centre to conduct the clinical trials will help in the faster launch of newer, more innovative, cosmetic,…
Complex Generic Guidance by US FDA to benefit Indian Pharma Formulators: Ind-Ra
Ind-Ra believes that select Indian pharmaceutical formulators with pending ANDA approvals or developmental pipelines in these…
Kilitch Drugs plans to start manufacturing operations in Ethiopia, Africa
Commercial production to commence from next financial year
Zydus Wellness to acquire Heinz India
The company gains iconic brands Complan, Glucon D and Nycil, which have a legacy of over 50 years
CPhI Worldwide records 44,500 attendees from 164 countries
CPhI Worldwide pharma survey shows improving outlook for pharma economies globally, with China and India showing the fastest…
‘Shantha Biotechnics’ Inactivated Polio Vaccine
Shantha Biotechnics,has received prequalification status from the World Health Organization (WHO)
MSF warns high prices of tuberculosis drug
Calls on US pharma corporation Johnson & Johnson to cut key TB drug price in half